Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 14/20 | 0.55 |
| ▸ | BRD4 | O60885 | 6/20 | 0.54 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.54 |
| ▸ | TNF | P01375 | 1/20 | 0.52 |
| ▸ | IL1B | P01584 | 1/20 | 0.52 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.52 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.52 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.52 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25757131 | 0.94 | CRBN (0.56) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL22252682 | 0.93 | CRBN (0.55) | CRBNBRD4STAT3TNFIL1B | |
| SCHEMBL23765963 | 0.92 | STAT3 (0.56) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL23766258 | 0.92 | STAT3 (0.56) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL23772826 | 0.91 | CRBN (0.55) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL20913681 | 0.91 | CRBN (0.55) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL17821424 | 0.91 | CRBN (0.55) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL18639838 | 0.91 | CRBN (0.55) | CRBNBRD4STAT3RIPK2TNF | |
| SCHEMBL21709494 | 0.91 | STAT3 (0.58) | CRBNBRD4STAT3RIPK2MAP1LC3B | |
| SCHEMBL30708006 | 0.91 | CRBN (0.59) | CRBNBRD4TNFIL1BIKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4134104-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | Eubulus Biotherapeutics Inc. (CN) | 2023-02-15 | — | — | EP | disclosed |